EUVIMEDEUVIMED entdecken
Crossref

Compounds identified by screening that inhibit the activity of transcription factor FOXO1/3a suppress dexamethasone-induced atrogin1 expression in C2C12 myoblasts

Manato Sakaue, Arisa Yamamoto, Takumi Onishi, Mamoru Oyabu, Yasutomi Kamei iD

Bioscience, Biotechnology, and Biochemistry · 20.05.2026 · 90 (6) · 785-790

DOI: 10.1093/bbb/zbag033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 06.03.2026. Verfasst von Manato Sakaue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Nutrition, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, 606-8522 Japan. Hauptthemen laut MEDLINE: Dexamethasone, Forkhead Box Protein O1, Myoblasts, Muscle Proteins. Die Arbeit nennt 41 Literaturangaben. Gefördert von: KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using a reporter assay system we screened a library of 472 compounds, and identified 1,25(OH)2D3, all-trans-retinoic acid, 9-cis-retinoic acid, 13-cis-retinoic acid, 17-allylamino-17-demethoxygeldanamycin, cantharidin, and magnolol that inhibit FOXO1/3a activity. These compounds suppressed the increase in Atrogin1 gene expression induced by dexamethasone in C2C12 myoblasts. Therefore, these compounds may prevent muscle atrophy by inhibiting FOXO1/3a activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneForkhead Box Protein O1MyoblastsMuscle ProteinsSKP Cullin F-Box Protein LigasesForkhead Box Protein O3Gene Expression RegulationAnimalsMiceCell LineDrug Evaluation, Preclinical

Stichwörter der Autor:innen

FOXO1/3adexamethasonemuscle atrophyscreeningskeletal muscle

Substanzen

DexamethasoneForkhead Box Protein O1Muscle ProteinsSKP Cullin F-Box Protein LigasesForkhead Box Protein O3Fbxo32 protein, mouseFoxo1 protein, mouseFoxO3 protein, mouse

Autor:innen und Institutionen

  • Laboratory of Molecular Nutrition, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, 606-8522 Japan.

ORCID-Profile: Yasutomi Kamei

Förderung

  • KAKENHI

Zitieren

APA

Sakaue, M., Yamamoto, A., Onishi, T., Oyabu, M., & Kamei, Y. (2026). Compounds identified by screening that inhibit the activity of transcription factor FOXO1/3a suppress dexamethasone-induced atrogin1 expression in C2C12 myoblasts. Bioscience, Biotechnology, and Biochemistry, 90(6), 785-790. https://doi.org/10.1093/bbb/zbag033

Vancouver

Sakaue M, Yamamoto A, Onishi T, Oyabu M, Kamei Y. Compounds identified by screening that inhibit the activity of transcription factor FOXO1/3a suppress dexamethasone-induced atrogin1 expression in C2C12 myoblasts. Bioscience, Biotechnology, and Biochemistry. 2026;90(6):785-790. doi:10.1093/bbb/zbag033

BibTeX
@article{Sakaue2026,
  author = {Sakaue, Manato and Yamamoto, Arisa and Onishi, Takumi and Oyabu, Mamoru and Kamei, Yasutomi},
  title = {Compounds identified by screening that inhibit the activity of transcription factor FOXO1/3a suppress dexamethasone-induced atrogin1 expression in C2C12 myoblasts},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2026},
  volume = {90},
  number = {6},
  pages = {785--790},
  doi = {10.1093/bbb/zbag033}
}
Kostenlos starten →